{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:25:30Z","timestamp":1787163930840,"version":"build-2736575974"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Z01 1ZID BC011242 and CL040015"],"award-info":[{"award-number":["Z01 1ZID BC011242 and CL040015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["HHSN26120150003I"],"award-info":[{"award-number":["HHSN26120150003I"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Maryland startup funds"},{"name":"NCI\/UMD Partnership for Integrative Cancer Research"},{"name":"NCI\/UMD Partnership for Integrative Cancer Research"},{"name":"NCI\/UMD Partnership for Integrative Cancer Research"},{"name":"NCI\/UMD Partnership for Integrative Cancer Research"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. A quarter of CRC patients develop liver metastases. Treatment options for liver metastases include surgically removing the tumors or undergoing liver transplantation; however, many patients are ineligible for these treatments due to severe extrahepatic disease or lack of suitable donors. Radiofrequency ablation offers an alternative local treatment modality for resolving CRC liver metastases and is known to generate antitumoral effects to stunt contralateral tumor growth. However, radiofrequency ablation is not suitable for tumors situated near critical structures or large blood vessels. Ethanol ablation is an alternative treatment option where pure ethanol is directly injected into tumors to induce necrosis and is unhindered by the drawbacks from radiofrequency ablation. The addition of ethyl cellulose with ethanol (EC-ethanol) enhances its retention within tissue and subsequently improves tumor ablative efficacy. However, the antitumoral response following EC-ethanol ablation in CRC tumors is poorly understood. Thus, we utilized a CRC murine model to investigate the immune effects following EC-ethanol treatment. Studies in the single flank model demonstrated up to a 27-fold increase in IL-6 and KC\/GRO pro-inflammatory cytokines within 6 hours post-treatment compared to sham treatments, along with a 4-fold increase in target-tissue necrosis and increased cytotoxic T-cells within the vicinity of the ablation zone over 7 days. Studies in the bilateral flank tumor model demonstrated that EC-ethanol ablation on the primary tumor resulted in a 1.6-fold increase in cytotoxic T-cells within the contralateral tumor after 7 days compared to the sham control group. Combining EC-ethanol treatment with radiofrequency ablation resulted in a more pronounced, 2-fold increase in cytotoxic T-cells within the contralateral tumor. Altogether, these results suggest that EC-ethanol potentiates antitumoral effects in CRC tumors and is a strong therapeutic candidate for treating CRC patients worldwide.<\/jats:p>","DOI":"10.1371\/journal.pone.0347625","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:33:46Z","timestamp":1776879226000},"page":"e0347625","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antitumoral immunity induced by gel ethanol ablation to treat unresectable colorectal cancer metastases in the liver"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7839-7277","authenticated-orcid":true,"given":"Jeffrey","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Morhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Huth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baktiar","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Karanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford J.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9206-5765","authenticated-orcid":true,"given":"Andrew S.","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5198-8491","authenticated-orcid":true,"given":"Jenna L.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"2","key":"pone.0347625.ref001","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","article-title":"Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN","volume":"72","author":"E Morgan","year":"2023","journal-title":"Gut"},{"issue":"6","key":"pone.0347625.ref002","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.21037\/jgo.2019.08.06","article-title":"Hepatic metastasis from colorectal cancer","volume":"10","author":"AWC Kow","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"pone.0347625.ref003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1463-1318.2010.02539.x","article-title":"Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series","volume":"14","author":"AEM van der Pool","year":"2012","journal-title":"Colorectal Dis"},{"issue":"4","key":"pone.0347625.ref004","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.canep.2014.04.004","article-title":"Patterns of metachronous metastases after curative treatment of colorectal cancer","volume":"38","author":"YRBM van Gestel","year":"2014","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"pone.0347625.ref005","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/bjs5.50299","article-title":"Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study","volume":"4","author":"V V\u00e4yrynen","year":"2020","journal-title":"BJS Open"},{"issue":"7","key":"pone.0347625.ref006","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review","volume":"325","author":"LH Biller","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"pone.0347625.ref007","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"RL Siegel","year":"2022","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"pone.0347625.ref008","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.surg.2023.02.032","article-title":"Surgery for colorectal liver metastases: Anatomic and non-anatomic approach","volume":"174","author":"T Rengers","year":"2023","journal-title":"Surgery"},{"issue":"10","key":"pone.0347625.ref009","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.23.01781","article-title":"Emerging Role of Liver Transplantation for Unresectable Colorectal Liver Metastases","volume":"42","author":"M Ch\u00e1vez-Villa","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0347625.ref010","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae367","article-title":"Liver transplantation for colorectal cancer with liver metastases","volume":"30","author":"BE Ueberroth","year":"2025","journal-title":"Oncologist"},{"issue":"2","key":"pone.0347625.ref011","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4254\/wjh.v11.i2.150","article-title":"Colorectal liver metastases: An update on multidisciplinary approach","volume":"11","author":"FC-L Chow","year":"2019","journal-title":"World J Hepatol"},{"issue":"2","key":"pone.0347625.ref012","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1477-2574.2012.00557.x","article-title":"Selection for hepatic resection of colorectal liver metastases: expert consensus statement","volume":"15","author":"RB Adams","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"7","key":"pone.0347625.ref013","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/bjs\/znaa145","article-title":"Centralized repeated resectability assessment of patients with colorectal\u2002liver metastases during first-line treatment: prospective study","volume":"108","author":"H Isoniemi","year":"2021","journal-title":"Br J Surg"},{"issue":"2","key":"pone.0347625.ref014","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(24)00660-0","article-title":"Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial","volume":"26","author":"S van der Lei","year":"2025","journal-title":"Lancet Oncol"},{"issue":"23","key":"pone.0347625.ref015","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.3748\/wjg.v12.i23.3716","article-title":"Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases","volume":"12","author":"J Hansler","year":"2006","journal-title":"World J Gastroenterol"},{"issue":"3","key":"pone.0347625.ref016","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/pharmaceutics16030315","article-title":"Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma","volume":"16","author":"J Seguin","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"pone.0347625.ref017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000454697","article-title":"Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease","volume":"33","author":"EN Petre","year":"2017","journal-title":"Visc Med"},{"issue":"1","key":"pone.0347625.ref018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2214\/ajr.164.1.7998542","article-title":"Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy","volume":"164","author":"MJ Lee","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"pone.0347625.ref019","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3748\/wjg.v11.i10.1426","article-title":"Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma","volume":"11","author":"K Kurokohchi","year":"2005","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pone.0347625.ref020","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1080\/02656736.2021.1977857","article-title":"Percutaneous ethanol injection enhanced the efficacy of radiofrequency ablation in the treatment of HCC: an insight into the mechanism of ethanol action","volume":"38","author":"Y Tan","year":"2021","journal-title":"Int J Hyperthermia"},{"issue":"2","key":"pone.0347625.ref021","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01888537","article-title":"Hepatic vascular and bile duct injury after ethanol injection therapy for hepatocellular carcinoma","volume":"17","author":"M Koda","year":"1992","journal-title":"Gastrointest Radiol"},{"issue":"1","key":"pone.0347625.ref022","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1038\/s41598-017-09371-2","article-title":"Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors","volume":"7","author":"R Morhard","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"pone.0347625.ref023","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1109\/TBME.2019.2960049","article-title":"Understanding Factors Governing Distribution Volume of Ethyl Cellulose-Ethanol to Optimize Ablative Therapy in the Liver","volume":"67","author":"R Morhard","year":"2020","journal-title":"IEEE Trans Biomed Eng"},{"issue":"19","key":"pone.0347625.ref024","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.3390\/cancers14194669","article-title":"Ethanol Ablation Therapy Drives Immune-Mediated Antitumor Effects in Murine Breast Cancer Models","volume":"14","author":"CA Nief","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"pone.0347625.ref025","doi-asserted-by":"crossref","first-page":"18229","DOI":"10.1038\/s41598-022-22279-w","article-title":"Comparative analysis of the immune response to RFA and cryoablation in a colon cancer mouse model","volume":"12","author":"M Mauda-Havakuk","year":"2022","journal-title":"Sci Rep"},{"key":"pone.0347625.ref026","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708810","article-title":"Local destruction of tumors and systemic immune effects","volume":"11","author":"KG Tranberg","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"pone.0347625.ref027","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1109\/TBME.2023.3340613","article-title":"Impact of Injection-Based Delivery Parameters on Local Distribution Volume of Ethyl-Cellulose Ethanol Gel in Tissue and Tissue Mimicking Phantoms","volume":"71","author":"G Adhikari","year":"2024","journal-title":"IEEE Trans Biomed Eng"},{"key":"pone.0347625.ref028","doi-asserted-by":"crossref","first-page":"119490","DOI":"10.1016\/j.biomaterials.2019.119490","article-title":"In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence","volume":"224","author":"X Han","year":"2019","journal-title":"Biomaterials"},{"issue":"6","key":"pone.0347625.ref029","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10696","article-title":"Light-activatable minimally invasive ethyl cellulose ethanol ablation: Biodistribution and potential applications","volume":"9","author":"J Yang","year":"2024","journal-title":"Bioeng Transl Med"},{"issue":"5","key":"pone.0347625.ref030","article-title":"Synergizing photodynamic therapy and ethanol ablation: Light-activatable sustained-exposure ethanol injection technology for enhanced tumor ablation","volume":"10","author":"C-H Ma","year":"2025","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"pone.0347625.ref031","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1148\/radiol.2511072175","article-title":"Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity","volume":"251","author":"SA Dromi","year":"2009","journal-title":"Radiology"},{"issue":"3","key":"pone.0347625.ref032","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jhep.2016.10.029","article-title":"Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma","volume":"66","author":"AG Duffy","year":"2017","journal-title":"J Hepatol"},{"issue":"9","key":"pone.0347625.ref033","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1744666X.2018.1516144","article-title":"The role of placebo effects in immune-related conditions: mechanisms and clinical considerations","volume":"14","author":"RM Smits","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"pone.0347625.ref034","article-title":"Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations","volume":"190","author":"SN Wong","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"pone.0347625.ref035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1148\/radiol.2442060826","article-title":"Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial","volume":"244","author":"Y-J Zhang","year":"2007","journal-title":"Radiology"},{"issue":"2","key":"pone.0347625.ref036","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3348\/kjr.2013.14.2.240","article-title":"Therapeutic efficacy and safety of percutaneous ethanol injection with or without combined radiofrequency ablation for hepatocellular carcinomas in high risk locations","volume":"14","author":"DI Cha","year":"2013","journal-title":"Korean J Radiol"},{"issue":"1","key":"pone.0347625.ref037","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"P Berraondo","year":"2019","journal-title":"Br J Cancer"},{"key":"pone.0347625.ref038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.sopen.2024.01.005","article-title":"Differential cytokine and chemokine expression after ablation vs. resection in colorectal cancer liver metastasis","volume":"18","author":"N Frenkel","year":"2024","journal-title":"Surg Open Sci"},{"key":"pone.0347625.ref039","doi-asserted-by":"crossref","first-page":"15330338231190644","DOI":"10.1177\/15330338231190644","article-title":"Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma","volume":"22","author":"D Guo","year":"2023","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"pone.0347625.ref040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cyto.2011.01.007","article-title":"IL-6 plays an essential role in neutrophilia under inflammation","volume":"54","author":"M Hashizume","year":"2011","journal-title":"Cytokine"},{"issue":"4","key":"pone.0347625.ref041","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002460","article-title":"IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors","volume":"9","author":"E Beyranvand Nejad","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"10","key":"pone.0347625.ref042","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"T Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"pone.0347625.ref043","doi-asserted-by":"crossref","first-page":"33123","DOI":"10.1038\/srep33123","article-title":"Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions","volume":"6","author":"KV Sawant","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"pone.0347625.ref044","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1160\/TH07-01-0040","article-title":"Chemokines as mediators of angiogenesis","volume":"97","author":"B Mehrad","year":"2007","journal-title":"Thromb Haemost"},{"issue":"1","key":"pone.0347625.ref045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13287-020-01755-y","article-title":"Proinflammatory cytokines regulate epidermal stem cells in wound epithelialization","volume":"11","author":"T Xiao","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"23","key":"pone.0347625.ref046","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in Inflammatory Disease","volume":"20","author":"S Kany","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pone.0347625.ref047","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jvir.2013.02.015","article-title":"Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10","volume":"24","author":"JP Erinjeri","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"pone.0347625.ref048","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jjco\/hyq010","article-title":"Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer","volume":"40","author":"K-Y Yeh","year":"2010","journal-title":"Jpn J Clin Oncol"},{"issue":"5","key":"pone.0347625.ref049","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1093722","article-title":"Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis","volume":"5","author":"BE Lippitz","year":"2016","journal-title":"Oncoimmunology"},{"issue":"8","key":"pone.0347625.ref050","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/ijms19082427","article-title":"Interaction between Tumor-Associated Dendritic Cells and Colon Cancer Cells Contributes to Tumor Progression via CXCL1","volume":"19","author":"Y-L Hsu","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0347625.ref051","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2214\/ajr.164.1.7998542","article-title":"Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy","volume":"164","author":"MJ Lee","year":"1995","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"pone.0347625.ref052","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3748\/wjg.v18.i10.1003","article-title":"Radiofrequency ablation or percutaneous ethanol injection for the treatment of liver tumors","volume":"18","author":"D Ansari","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"7","key":"pone.0347625.ref053","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.it.2013.03.005","article-title":"Adaptive immunity after cell death","volume":"34","author":"S Zelenay","year":"2013","journal-title":"Trends Immunol"},{"issue":"1","key":"pone.0347625.ref054","doi-asserted-by":"crossref","first-page":"9904","DOI":"10.1038\/s41598-019-46410-6","article-title":"Development of orthotopic tumour models using ultrasound-guided intrahepatic injection","volume":"9","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0347625.ref055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12885-025-13834-5","article-title":"Establishment of a novel mouse model of colorectal cancer by orthotopic transplantation","volume":"25","author":"C Chen","year":"2025","journal-title":"BMC Cancer"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:33:53Z","timestamp":1776879233000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347625"}},"subtitle":[],"editor":[{"given":"Ashraf","family":"Elbahrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0347625","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]}}}